Company: ARTL
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001640334-25-001429
Chunk: 504

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 4
Chunk 504
---
Not Applicable.

Item 5. Other Information

Securities Trading Plans of Directors and Executive Officers

During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408. 

 71Table of Contents

Item 6. Exhibits

ExhibitNumber Description Form File No. FilingDate FiledHerewith3.1 Articles of Incorporation, as amended 10-Q  001-38951  05/11/2023  3.2 Amended and Restated Bylaws 8-K 001-38951 04/21/2023 10.1 At-The-Market Offering Agreement, dated July 18, 2025, between Artelo Biosciences, Inc. and R.F. Lafferty & Co., Inc. (incorporated by reference to Exhibit 1.1 to the Company’s Form 8-K filed with the SEC on July 18, 2025) 8-K 001-38951 07/18/2025  10.2 Securities Purchase Agreement, dated June 24, 2025, between Artelo Biosciences, Inc. and the Purchasers named therein 8-K 001-38951 06/26/2025  10.3 Form of Subscription Agreement by and between Artelo Biosciences Inc. and the purchasers named therein 8-K 001-38951 05/01/2025  10.4 Form of Pre-Funded Warrant 8-K 001-38951 06/26/2025  10.5 Form of $5.82 Warrant 8-K 001-38951 06/26/2025  10.6 Form of $10.00 Warrant 8-K 001-38951 06/26/2025  10.7 Form of Convertible Note 8-K 001-38951 05/01/2025  10.8 Form of Warrant 8-K 001-38951 05/01/2025  31.1 Section 302 Certification       *